172 related articles for article (PubMed ID: 31564693)
21. Comparison of Characteristics of
Fujita T; Yoshida H; Osaka S; Hirose Y; Goto M; Nagano N; Takahashi T
Ann Lab Med; 2019 Sep; 39(5):488-492. PubMed ID: 31037868
[TBL] [Abstract][Full Text] [Related]
22. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing.
Woo PC; Fung AM; Lau SK; Wong SS; Yuen KY
J Clin Microbiol; 2001 Sep; 39(9):3147-55. PubMed ID: 11526143
[TBL] [Abstract][Full Text] [Related]
23. Comparative genome analysis of three Group A
Ishihara H; Ogura K; Nguyen VA; Miyoshi-Akiyama T; Okamoto S; Takemoto N
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33533709
[No Abstract] [Full Text] [Related]
24. Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis.
Woo PC; Teng JL; Lau SK; Lum PN; Leung KW; Wong KL; Li KW; Lam KC; Yuen KY
J Clin Microbiol; 2003 Feb; 41(2):613-8. PubMed ID: 12574255
[TBL] [Abstract][Full Text] [Related]
25. Distribution of emm types and genetic characterization of the mgc locus in group G Streptococcus dysgalactiae subsp. equisimilis from a hospital in northern Taiwan.
Tseng SP; Lin YY; Tsai JC; Hsueh PR; Chen HJ; Hung WC; Teng LJ
J Clin Microbiol; 2010 Aug; 48(8):2975-7. PubMed ID: 20573871
[TBL] [Abstract][Full Text] [Related]
26. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections.
Takahashi T; Sunaoshi K; Sunakawa K; Fujishima S; Watanabe H; Ubukata K;
Clin Microbiol Infect; 2010 Aug; 16(8):1097-103. PubMed ID: 19732082
[TBL] [Abstract][Full Text] [Related]
27. Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features.
Takahashi T; Ubukata K; Watanabe H
J Infect Chemother; 2011 Feb; 17(1):1-10. PubMed ID: 20607346
[TBL] [Abstract][Full Text] [Related]
28. Pathologic and molecular characterization of
Oh SI; Kim JW; Jung JY; Chae M; Lee YR; Kim JH; So B; Kim HY
J Vet Sci; 2018 Mar; 19(2):313-317. PubMed ID: 29284213
[No Abstract] [Full Text] [Related]
29. Genetic diversity and virulence properties of Streptococcus dysgalactiae subsp. equisimilis from different sources.
Gherardi G; Imperi M; Palmieri C; Magi G; Facinelli B; Baldassarri L; Pataracchia M; Creti R
J Med Microbiol; 2014 Jan; 63(Pt 1):90-98. PubMed ID: 24149625
[TBL] [Abstract][Full Text] [Related]
30. Streptococcus dysgalactiae subsp. equisimilis from invasive and non-invasive infections in Spain: combining epidemiology, molecular characterization, and genetic diversity.
Rojo-Bezares B; Toca L; Azcona-Gutiérrez JM; Ortega-Unanue N; Toledano P; Sáenz Y
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1013-1021. PubMed ID: 33392783
[TBL] [Abstract][Full Text] [Related]
31. Biofilm formation of beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates and its association with emm polymorphism.
Ma JS; Chen SY; Lo HH
APMIS; 2017 Nov; 125(11):1027-1032. PubMed ID: 28885723
[TBL] [Abstract][Full Text] [Related]
32. Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.
Jensen A; Kilian M
J Clin Microbiol; 2012 Jan; 50(1):113-26. PubMed ID: 22075580
[TBL] [Abstract][Full Text] [Related]
33. PCR based differentiation between Streptococcus dysgalactiae subsp. equisimilis strains isolated from humans and horses.
Preziuso S; Pinho MD; Attili AR; Melo-Cristino J; Acke E; Midwinter AC; Cuteri V; Ramirez M
Comp Immunol Microbiol Infect Dis; 2014 May; 37(3):169-72. PubMed ID: 24813401
[TBL] [Abstract][Full Text] [Related]
34. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
[TBL] [Abstract][Full Text] [Related]
35. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage.
Silva LG; Genteluci GL; Corrêa de Mattos M; Glatthardt T; Sá Figueiredo AM; Ferreira-Carvalho BT
J Med Microbiol; 2015 May; 64(Pt 5):551-558. PubMed ID: 25752850
[TBL] [Abstract][Full Text] [Related]
36. Exploring the arthritogenicity of Streptococcus dysgalactiae subspecies equisimilis.
Oppegaard O; Mylvaganam H; Skrede S; Kittang BR
BMC Microbiol; 2018 Feb; 18(1):17. PubMed ID: 29482512
[TBL] [Abstract][Full Text] [Related]
37. First molecular evidence of intrauterine and surgical-site infections caused by Streptococcus dysgalactiae subsp. equisimilis.
Lu B; Diao B; Fang Y; Shi Y; Zhu F; Li D; Zhang S; Cui Y; Wang D
J Infect Dev Ctries; 2016 Jun; 10(6):673-7. PubMed ID: 27367018
[TBL] [Abstract][Full Text] [Related]
38. Detection of Streptococcus pyogenes virulence genes in Streptococcus dysgalactiae subsp. equisimilis from Vellore, India.
Babbar A; Itzek A; Pieper DH; Nitsche-Schmitz DP
Folia Microbiol (Praha); 2018 Sep; 63(5):581-586. PubMed ID: 29532420
[TBL] [Abstract][Full Text] [Related]
39. Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis.
Watanabe S; Takemoto N; Ogura K; Miyoshi-Akiyama T
Microbiol Immunol; 2016 Jan; 60(1):1-9. PubMed ID: 26762200
[TBL] [Abstract][Full Text] [Related]
40. [Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen].
Katsukawa C; Tamaru A; Morikawa Y
Kansenshogaku Zasshi; 2002 Mar; 76(3):155-60. PubMed ID: 11974882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
